Abstract
In our previous study, we have demonstrated that plasminogen activators (PAs) with Mr=24, 000 and Mr=48, 000 play an important role in tissue fibrinolysis during the development of hypersensitivity granulomas. In order to investigate the cellular source of these PAs, we cultured mouse peritoneal macrophages in different conditions. C57BL/6N mice were used with or without infection by Mycobacterium lepraemurium. Antigen stimulated peritoneal exudate macrophages were obtained by intraperitoneal injection of sonicated M. lepraemurium to the infected mice. PA activity in conditioned media was assayed by using two-stage colorimetric method and electrophoretic enzymography. Resident peritoneal macrophages secreted PA with Mr=48, 000. However antigen stimulated peritoneal exudate macrophages secreted a high activity of PA with Mr=24, 000 in addition to Mr=48, 000. In order to investigate secretion mechanism, in vitro stimulation of macrophages was carried out by lymphokines which were obtained from culture supernatants of splenic cells exposed with antigen or splenic T cells with Concanavalin A. The results clearly demonstrated that macrophages became secretable of PA with Mr=24, 000 by lymphokine stimulation. Further experiments showed that the effect of lymphokine to induce secretion of PA was partially represented by γ-Interferon. These data indicated that the immunological stimulation induced macrophages to secrete PA, the molecular weight of which was altered from resident macrophages.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.